An overview on nanoparticle-based strategies to fight viral infections with a focus on COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nan...

Full description

Saved in:
Bibliographic Details
Published in:Journal of nanobiotechnology 2022-10, Vol.20 (1), p.1-26, Article 440
Main Authors: Yasamineh, Saman, Kalajahi, Hesam Ghafouri, Yasamineh, Pooneh, Yazdani, Yalda, Gholizadeh, Omid, Tabatabaie, Raheleh, Afkhami, Hamed, Davodabadi, Fatemeh, farkhad, Alireza Khanalipour, Pahlevan, Daryoush, Firouzi-Amandi, Akram, Nejati-Koshki, Kazem, Dadashpour, Mehdi
Format: Article
Language:English
Subjects:
Complications and side effects
Coronaviruses
COVID-19
Delivery systems
Health services
Infections
Nanomedicine
Nanoparticles
Nanotechnology
Nanovaccines
Pandemics
Polylactic acid
Prevention
Respiratory diseases
Review
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccine development
Vaccines
Viral diseases
Viral infection
Viral infections
Virus diseases
Viruses
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to COVID-19 and has become a pandemic worldwide with mortality of millions. Nanotechnology can be used to deliver antiviral medicines or other types of viral reproduction-inhibiting medications. At various steps of viral infection, nanotechnology could suggest practical solutions for usage in the fight against viral infection. Nanotechnology-based approaches can help in the fight against SARS-CoV-2 infection. Nanoparticles can play an essential role in progressing SARS-CoV-2 treatment and vaccine production in efficacy and safety. Nanocarriers have increased the speed of vaccine development and the efficiency of vaccines. As a result, the increased investigation into nanoparticles as nano-delivery systems and nanotherapeutics in viral infection, and the development of new and effective methods are essential for inhibiting SARS-CoV-2 infection. In this article, we compare the attributes of several nanoparticles and evaluate their capability to create novel vaccines and treatment methods against different types of viral diseases, especially the SARS-CoV-2 disease.
ISSN:1477-3155
1477-3155
DOI:10.1186/s12951-022-01625-0